Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HALDOL

HALOPERIDOL LACTATE

Standard Dose
EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview HALDOL is listed in Drugs@FDA under application 015922 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient HALOPERIDOL LACTATE Form and strength CONCENTRATE;ORAL - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORTHO MCNEIL Submission history Latest submission status date: 2002-04-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview HALDOL is listed in Drugs@FDA under application 015922 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient HALOPERIDOL LACTATE Form and strength CONCENTRATE;ORAL - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORTHO MCNEIL Submission history Latest submission status date: 2002-04-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.